Exploring the Regulatory Parameters of Digital Pathology in Precision Medicine to Guide Patient Selection & Protocol Design

• Utilizing unique AI-powered digital pathology insights to inform patient stratification and selection
• Integrating digital pathology early into trial design to safeguard clinical success downstream
• Navigating device and software requirements for use of digital pathology in clinical trials

Speakers:

Emily Finnegan

Director - Global Regulatory Affairs, Precision Medicine Digital Health

GSK